卵巢腺癌的临床试验
总计13841个结果
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer Center完全的
-
Centre Francois BaclesseARCAGY/ GINECO GROUP; French Cancer Research Hospital Program完全的Platinum-resistant or Refractory Ovarian Cancer法国
-
AstraZenecaMyriad Genetic Laboratories, Inc.撤销
-
New Mexico Cancer Care AllianceCelgene Corporation终止
-
Gynecologic Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Southwest Oncology Group; Cancer...终止
-
Northwestern UniversityNational Cancer Institute (NCI)完全的
-
Garden State Cancer Center at the Center for Molecular...National Cancer Institute (NCI)完全的
-
CanariaBio Inc.Korean Cancer Study Group招聘中
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)完全的
-
NYU Langone HealthNational Cancer Institute (NCI)完全的
-
Centre Francois BaclesseGroupement Interrégional de Recherche Clinique et d'Innovation完全的
-
Taipei Veterans General Hospital, TaiwanNational YangMing University完全的
-
Women's Hospital School Of Medicine Zhejiang University招聘中
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.招聘中
-
Haukeland University HospitalHelse Stavanger HF; Sorlandet Hospital HF招聘中
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.完全的非胚系 BRCA 突变卵巢癌意大利, 西班牙, 瑞典, 加拿大, 捷克语, 波兰, 英国, 以色列, 奥地利, 比利时, 瑞士, 荷兰, 保加利亚, 芬兰, 挪威, 丹麦, 斯洛文尼亚, 葡萄牙
-
AstraZeneca完全的
-
Icahn School of Medicine at Mount Sinai撤销
-
Jonsson Comprehensive Cancer Center完全的
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering Institute完全的
-
Montefiore Medical CenterNational Cancer Institute (NCI)完全的
-
PEDRO VILLAREJO CAMPOSUniversity of Castilla-La Mancha; Hospital General de Ciudad Real未知
-
Charite University, Berlin, Germany撤销
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)终止
-
Astellas Pharma IncOSI Pharmaceuticals完全的